Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

78 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Aminoglycoside nephrotoxicity.
Swan SK. Swan SK. Semin Nephrol. 1997 Jan;17(1):27-33. Semin Nephrol. 1997. PMID: 9000547 Review.
Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial.
Swan SK, Rudy DW, Lasseter KC, Ryan CF, Buechel KL, Lambrecht LJ, Pinto MB, Dilzer SC, Obrda O, Sundblad KJ, Gumbs CP, Ebel DL, Quan H, Larson PJ, Schwartz JI, Musliner TA, Gertz BJ, Brater DC, Yao SL. Swan SK, et al. Ann Intern Med. 2000 Jul 4;133(1):1-9. doi: 10.7326/0003-4819-133-1-200007040-00002. Ann Intern Med. 2000. PMID: 10877734 Clinical Trial.
Pharmacokinetics, safety, and tolerability of gadoversetamide injection (OptiMARK) in subjects with central nervous system or liver pathology and varying degrees of renal function.
Swan SK, Baker JF, Free R, Tucker RM, Barron B, Barr R, Seltzer S, Gazelle GS, Maravilla KR, Barr W, Stevens GR, Lambrecht LJ, Pierro JA. Swan SK, et al. J Magn Reson Imaging. 1999 Feb;9(2):317-21. doi: 10.1002/(sici)1522-2586(199902)9:2<317::aid-jmri25>;2-b. J Magn Reson Imaging. 1999. PMID: 10077031 Clinical Trial.
78 results